DeutschNewstral
Article
Ttwincities.com on 2020-04-10 15:03
Hennepin Healthcare joins trial on potential coronavirus therapy remdesivir
Related news
Hennepin Healthcare CEO to resignStar Tribune- Hennepin Healthcare picks new leaderStar Tribune
Hennepin Healthcare joins homeless advocates in tiny-house planbizjournals.com- Hennepin Healthcare hires first chief health equity officerStar Tribune
- THennepin Healthcare suspends trial of paramedics administering ketaminetwincities.com
- Hennepin Healthcare cuts ties with sheriff, considers armed securityStar Tribune
- Preemie graduates from Hennepin Healthcare after 515-day hospital stayStar Tribune
- Novel hyperbaric treatment at Hennepin Healthcare helps save toddler's earStar Tribune
- Hennepin Healthcare to release ketamine reviews Thursday afternoonStar Tribune
- Hennepin Healthcare expands health equity department, releases first annual reportStar Tribune
- Hennepin Healthcare will ask third party to review ketamine casesStar Tribune
- Patients sedated by ketamine were enrolled in Hennepin Healthcare studyStar Tribune
- Hennepin Healthcare, North Memorial discontinue hospital merger talksStar Tribune
- More Hennepin Healthcare studies to be suspended in sedation debateStar Tribune
Top Projects of 2018: Hennepin Healthcare – Clinic and Specialty Centerfinance-commerce.com- St. Paul joins other cities banning conversion therapyStar Tribune
- HCMC rebrands as Hennepin Healthcarebizjournals.com
- Hennepin Healthcare names new CEObizjournals.com
- TLook for those $1,200 stimulus checks to be hitting your bank account soontwincities.com
- TDakota County to host PPE donation drive next weektwincities.com